Speaker Profile
Peter Campbell

Peter Campbell PhD

Genetics, Research and Clinical Research, Haematology
Hinxton, England, United Kingdom

Connect with the speaker?

Dr. Peter Campbell is the Head of the Cancer, Ageing, and Somatic Mutation program at the Wellcome Sanger Institute. His research focuses on the use of next-generation sequencing technologies for annotating cancer genomes. He is also a practicing hematologist at Addenbrooke's Hospital in Cambridge.

After completing his specialist training in Haematology in 2002 in Australia and New Zealand, Peter earned his PhD in the molecular pathogenesis and clinical management of myeloproliferative disorders at the University of Cambridge. Peter remains the co-clinical lead on the largest randomized clinical trial in essential thrombocythaemia, a common chronic hematological malignancy.

In 2007 Peter moved to the Sanger Institute where he joined the Cancer Genome Project on a Kay Kendall Leukaemia Fund Clinical Fellowship. Since joining the Institute, he has pioneered the development of protocols for identifying somatically acquired mutations from massively parallel sequencing data. In 2009 Peter was the senior author of the first complete high-coverage sequence and analysis of a whole cancer genome associated with tobacco smoke exposure.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)